Both in Pharmaceuticals
iBio vs Werewolf Therapeutics
Over the past year IBIO returned −47.7% and HOWL returned −9.9%; their daily moves had a correlation of 0.15.
IBIO −47.7% HOWL −9.9%Growth of $1, one year, split-adjusted
| Metric | IBIO | HOWL |
|---|---|---|
| Price | $0.8000 | $1.09 |
| Market cap | $51.4M | $53.0M |
| Today | −2.85% | +1.87% |
| 1 month | −23.8% | +18.5% |
| 6 months | −54.8% | +67.6% |
| Year to date | −58.5% | +72.1% |
| 1 year | −54.5% | −16.8% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | 100.0% |
| Net margin | — | 17.5% |
| P/E (TTM) | — | — |
| Price / sales | 514.5× | 2.5× |
| Net cash | $88.0M | $22.0M |
| Dividend yield | — | — |
| Volatility (60d) | 65.6% | 152.4% |
| Short % of float | 6.8% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).